Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$8.00 – $14.00
34% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $793.86B | $755.23B | $730.54B | $868.87B | $881.92B | $936.21B | $997.33B | $1.02T |
| Cost of revenue | $314.16B | $310.67B | $302.56B | $274.13B | $319.23B | $311.09B | $313.63B | $358.83B |
| Gross profit | $479.70B | $444.56B | $427.99B | $475.99B | $562.70B | $625.12B | $683.70B | $658.21B |
| Gross margin | 60.4% | 58.9% | 58.6% | 54.8% | 63.8% | 66.8% | 68.6% | 64.7% |
| R&D | $94.00B | $91.60B | $23.20B | $85.30B | $76.87B | $86.40B | $566.3M | $110.64B |
| Operating income | $72.17B | $101.60B | $102.50B | $166.30B | $186.61B | $151.89B | $162.46B | $147.94B |
| EBITDA | $89.13B | $162.27B | $160.81B | $233.16B | $238.82B | $112.10B | $232.37B | $215.57B |
| Net income | $8.15B | $60.60B | $12.92B | $115.74B | $143.43B | $242.57B | $117.86B | $68.60B |
| Net margin | 1.0% | 8.0% | 1.8% | 13.3% | 16.3% | 25.9% | 11.8% | 6.7% |
| EPS (diluted) | 5.96 | 61.15 | 51.00 | 90.17 | 108.65 | 21.88 | 102.80 | 62.31 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $1.06T | $90.65 | $87.06–$93.67 | 1 |
| 2028 | $1.11T | $109.22 | $104.89–$112.86 | 1 |
| 2029 | $1.16T | $120.53 | $115.76–$124.55 | 1 |
| 2030 | $1.21T | $138.18 | $132.71–$142.79 | 1 |
Forward consensus · source: Financial Modeling Prep
OLYMPUS CORP ORD
No one on the platform currently holds OCPNF.
No tracked institution reports a position in OCPNF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2027-03-31 | $30.0000 | |
| 2026-03-31 | $30.0000 | 2026-06-04 |
| 2025-03-31 | $20.0000 | 2025-06-05 |
| 2024-03-28 | $18.0000 | 2024-06-05 |
No one on the platform has traded OCPNF yet.
| +0.00% |
| $11.2B |
| — |
| ERFSFEurofins Scientific SE | $76.93 | +0.58% | $13.3B | — |
| FSPKFFisher & Paykel Healthcare Corporation Limited | $22.52 | +0.00% | $13.2B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.1× earnings vs its 0.2× historical median P/E.
Fair value ≈ $16.85 · price $10.01 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.